Columbia Care

The Analyst Pablo Zuanic, from Cantor Fitzgerald, rated Columbia Care Inc. (OTC: CCHWF) as Overweight with a price target of $5.10. The Thesis Columbia Care reported its unaudited financial and operating results for the first quarter ended March 31, 2022, on Monday. The firm reported revenue of $...

The Analyst: Pablo Zuanic, from Cantor Fitzgerald, rated Cresco Labs, Inc. (OTC: CRLBF) as Overweight with a price target of $19.00. The Thesis: According to Zuanic, the acquisition of Columbia Care (OTC: CCHWF) fits a logical M&A that is characteristic of the industry's ongoing...

The cannabis market is changing more quickly than anyone expected, Columbia Care Inc. (OTC: CCHWF) CEO Nicholas Vita said this week at the Benzinga Cannabis Capital Conference in Miami Beach. Two-Pronged No More The industry is at a crossroads, the cannabis CEO said: companies must realize that...

The SALT Conference is a prestigious gathering of the most well-known executives in finance, policy, economics and beyond. Benzinga headed to Las Vegas to cover them.  Nicholas Vita, vice chairman and CEO of the medical cannabis company Columbia Care, discussed the opioid crisis, the...